• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[浆液性卵巢交界性肿瘤]

[Serous borderline ovarian tumors].

作者信息

Zipprich K, Albrecht G, Canzler E

出版信息

Zentralbl Gynakol. 1985;107(3):159-68.

PMID:3984570
Abstract

Proliferating papillary serous cystadenomas that seldom occur are classified into the group of ovarian tumours of low malignant potential (borderline tumours). The present study includes 33 cases observed in our clinic since 1955. Even though the five-year survival rate being 88% was substantially higher than that for ovarian carcinomas, the prognosis of individual cases cannot be reliably predicted because of the uncertainty as to the biological behaviour in both clinical and histological terms. Consequently, the trend to predominantly radical surgery appears to be a justified approach. Whenever it is desirable to maintain fertility in younger women, conservative surgery would require a unilateral tumour without a ruptured capsule and normal histological findings to be obtained from wedge excision in the opposite ovary.

摘要

罕见的增殖性乳头状浆液性囊腺瘤被归类为低恶性潜能卵巢肿瘤(交界性肿瘤)组。本研究包括自1955年以来在我们诊所观察到的33例病例。尽管五年生存率为88%,显著高于卵巢癌,但由于临床和组织学方面生物学行为的不确定性,个别病例的预后无法可靠预测。因此,主要采取根治性手术的趋势似乎是一种合理的方法。每当希望保留年轻女性的生育能力时,保守手术需要对侧卵巢楔形切除获得的肿瘤为单侧、包膜未破裂且组织学检查结果正常。

相似文献

1
[Serous borderline ovarian tumors].[浆液性卵巢交界性肿瘤]
Zentralbl Gynakol. 1985;107(3):159-68.
2
[Serous and mucinous ovarian cystadenomas at the limit of malignancy].[处于恶性边缘的浆液性和黏液性卵巢囊腺瘤]
Schweiz Med Wochenschr. 1980 Apr 5;110(14):531-9.
3
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.伴有非侵袭性种植的卵巢浆液性交界性肿瘤的复发率和总生存率与时间相关。
Am J Surg Pathol. 2006 Nov;30(11):1367-71. doi: 10.1097/01.pas.0000213294.81154.95.
4
Clinical factors and biomarkers in ovarian tumors development.卵巢肿瘤发生发展中的临床因素和生物标志物
Rom J Morphol Embryol. 2008;49(3):327-38.
5
[Borderline tumors of the ovary: a multicenter study in 137 patients].[卵巢交界性肿瘤:137例患者的多中心研究]
J Gynecol Obstet Biol Reprod (Paris). 2001 May;30(3):272-81.
6
Management of borderline ovarian tumors.卵巢交界性肿瘤的管理
Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1069-75.
7
[Borderline ovarian tumors. Retrospective analysis of 20 cases].[卵巢交界性肿瘤。20例回顾性分析]
Minerva Ginecol. 2001 Feb;53(1 Suppl 1):97-9.
8
[Clinical-pathological relationships of potenially malignant cystadenomas of the ovaries].[卵巢潜在恶性囊腺瘤的临床病理关系]
Zentralbl Gynakol. 1978;100(15):978-84.
9
[Our experience in treating ovarian tumors with borderline malignancy].[我们治疗交界性恶性卵巢肿瘤的经验]
Akush Ginekol (Sofiia). 2000;39(1):39-41.
10
Conservative treatment of borderline ovarian tumors.卵巢交界性肿瘤的保守治疗
Obstet Gynecol. 1985 Sep;66(3):417-22.

引用本文的文献

1
[Early forms of ovarian cancer--are there borderline tumors?].
Arch Gynecol Obstet. 1989;245(1-4):588-95. doi: 10.1007/BF02417448.